Deep Track Capital, LP Ionis Pharmaceuticals Inc Transaction History
Deep Track Capital, LP
- $2.82 Billion
- Q2 2025
A detailed history of Deep Track Capital, LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Deep Track Capital, LP holds 4,891,544 shares of IONS stock, worth $299 Million. This represents 6.86% of its overall portfolio holdings.
Number of Shares
4,891,544
Previous 4,564,207
7.17%
Holding current value
$299 Million
Previous $138 Million
40.35%
% of portfolio
6.86%
Previous 4.81%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
413Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.02 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$981 Million0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$766 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$631 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$480 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $8.67B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...